Acadian Asset Management LLC Cyclerion Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.96 - $1.78 $17,126 - $31,755	-17,840 Reduced 7.14%	231,952 $256,000
Q4 2021 Feb 10, 2022	BUY	$1.56 - $2.99 $389,675 - $746,878	249,792 New	249,792 $428,000
Q1 2021 May 11, 2021	SELL	$2.69 - $5.12 $138,400 - $263,424	-51,450 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$2.25 - $7.12 $27,247 - $86,223	12,110 Added 30.78%	51,450 $157,000
Q3 2020 Nov 09, 2020	SELL	$3.46 - $8.39 $393,640 - $954,521	-113,769 Reduced 74.31%	39,340 $239,000
Q2 2020 Aug 12, 2020	BUY	$2.37 - $7.14 $107,434 - $323,663	45,331 Added 42.06%	153,109 $905,000
Q1 2020 May 11, 2020	BUY	$2.46 - $5.84 $17,025 - $40,418	6,921 Added 6.86%	107,778 $285,000
Q4 2019 Feb 06, 2020	BUY	$1.8 - $13.43 $181,542 - $1.35 Million	100,857 New	100,857 $274,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.